Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhancement of clonogenicity of human multiple myeloma by dendritic cells.

The Journal of experimental medicine - 7 Aug 2006

Kukreja Anjli, Hutchinson Aisha, Dhodapkar Kavita, Mazumder Amitabha, Vesole David, Angitapalli Revathi, Jagannath Sundar, Dhodapkar Madhav V

Abstract excerpt

Infiltration by dendritic cells (DCs) is a common feature of most human tumors. Prior studies evaluating the interaction of DCs with tumors have focused largely on their immunologic properties (for review see Banchereau, J., and R.M. Steinman. 1998. Nature. 392:245-252). In this study, we show that the clonogenicity of several human tumor cell lines and primary tumor cells from myeloma patients is enhanced by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Coculture Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Membrane Glycoproteins

Share to Multiple Myeloma

Share to Proteoglycans

Share to Syndecan-1

Share to Tumor Stem Cell Assay

Source

Open in PubMed Open full text

Identifiers

PMID: 16880256
DOI: 10.1084/jem.20052136
PMCID: PMC2034506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhancement of clonogenicity of human multiple myeloma by dendritic cells.PMID 16880256Read ↗

Dendritic cell–mediated activation-induced cytidine deaminase (AID)–dependent induction of genomic instability in human myelomaSemantic proximity Read ↗

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitroSemantic proximity Read ↗

Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.Semantic proximity Read ↗

Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Semantic proximity Read ↗

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.Semantic proximity Read ↗

Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.Semantic proximity Read ↗

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.Semantic proximity Read ↗

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple MyelomaSemantic proximity Read ↗

Characterization of clonogenic multiple myeloma cellsSemantic proximity Read ↗

Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.Semantic proximity Read ↗

Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.Semantic proximity Read ↗

Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.